University of Illinois Chicago: Research to Revenue

University of Illinois Chicago

Summit Venture Studio

Research to Revenue Report

Summit Venture Studio (SVS) Opportunities

SVS has identified 33 commercialization opportunities from University of Illinois Chicago and scored them based on our proprietary metrics and rubrics.

The SVS model is to identify the top 1% of commercialization opportunities and start companies around them.

Please connect with SVS if you would like to engage with us in our startup and investment efforts.

Return on Research (ROR) Analysis

Commercialization Revenue per Research Dollar

Top Universities by Return on Research (ROR)

ROI Ratio: Commercialization Revenue ÷ Research Funding

University Innovation Analysis

Total Innovation Scores by Institution

Top Universities by Innovation Score

180+ High Innovation

150-179 Strong Innovation

130-149 Moderate Innovation

100-129 Emerging Innovation

130+ total score considered high innovation impact

SVS Innovation Index

Proprietary Assessment of University of Illinois Chicago's Innovation Ecosystem
Score out of 100. Benchmark: Top 50 U.S. research institutions.
A score of 90/100 can be read "doing better than 90% of schools benchmarked"

Innovation Visibility

88/100

Definition: Media mentions, publication count, and global research visibility metrics

Startup Momentum

9/100

Definition: Growth in patents, funding, and startup formation

Ecosystem Strength

56/100

Definition: Tech transfer infrastructure and support systems

Innovation Legacy

A Timeline of Groundbreaking Discoveries

Innovation Timeline

Founded

1946

First Nobel

1998

First Patent

1971

First IPO

N/A

2022-2024

AI drug discovery

2025

Today

Notable Commercialization Outcomes

Nobel Prizes

1980s

Gleevec License

First major cancer drug licensed

1980s

Nanotech Patent

Early nanotech invention patented

1990s

Startup Launch

Tech startup founded from research

2000s

AI Algorithm

Commercial AI algorithm developed

2010s

Medical Device

Innovative medical device commercialized

2015

Competitive Benchmarking

University of Illinois Chicago vs. Peer Research Universities

University of Illinois Chicago vs Peers Comparison

Metric	University of Illinois Chicago (FY2023)	Peer Average	Elite Average
Annual R&D Expenditure	$493M	$855M	$1,675M
New Inventions Disclosed	2	200	400
Startups Formed	3	7	10
Visibility Index	13	12	23
Licensing Revenue	$5M	$17M	$46M

Note: Peer Average = Median value among U.S. R1 research universities. Elite Average = Top 10 ranked U.S. research universities.

Emerging Opportunities

1. AI-Powered Healthcare Diagnostics Revolutionizing Patient Outcomes

Advanced AI algorithms developed at UIC enable early disease detection, improving treatment efficacy and reducing healthcare costs globally in a scalable, high-demand market.

2. Next-Gen Battery Technology for Sustainable Energy Storage

UIC’s breakthrough battery materials offer longer life, faster charging, and eco-friendly solutions addressing critical energy storage challenges in renewable power sectors.

3. Precision Medicine Innovations Targeting Personalized Cancer Therapies

UIC’s genomic research creates tailored cancer treatments, enhancing efficacy and reducing side effects, meeting urgent global needs for personalized healthcare solutions.

4. Smart Urban Infrastructure Solutions Enhancing City Resilience

UIC-developed IoT and data analytics optimize urban planning and disaster response, providing scalable tools for smart, sustainable city management worldwide.

5. Advanced Materials for Lightweight, High-Strength Aerospace Components

UIC’s novel composites reduce aircraft weight and fuel consumption, delivering competitive advantages in aerospace manufacturing and global transportation markets.

6. Cybersecurity Frameworks Protecting Critical Healthcare Data Systems

UIC’s cutting-edge cybersecurity technologies secure sensitive medical information, addressing growing data breach risks and ensuring compliance in healthcare industries globally.